Evidence map›Paper›PMID 31717575›Full record

ReviewTropical medicine and infectious disease2019

A Case History in Cooperative Biological Research: Compendium of Studies and Program Analyses in Kazakhstan.

Kenneth B Yeh, Falgunee K Parekh, Lyazzat Musralina, Ablay Sansyzbai, Kairat Tabynov, Zhanna Shapieva, Allen L Richards, John Hay

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kenneth B YehMRIGlobal, Gaithersburg, MD 20878, USA.
Falgunee K ParekhEpiPointe, LLC, Cary, NC 27518, USA.
Lyazzat MusralinaDepartment of Molecular Biology and Genetics, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Ablay SansyzbaiDepartment of Biological Safety, Kazakh National Agrarian University, Almaty 050010, Kazakhstan.
Kairat TabynovDepartment of Biological Safety, Kazakh National Agrarian University, Almaty 050010, Kazakhstan.
Zhanna ShapievaDepartment of Parasitic Diseases, Scientific Practical Center for Sanitary Epidemiological Expertise and Monitoring, Almaty 050008, Kazakhstan.
Allen L RichardsDepartment of Preventative Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
John HayDepartment of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY 14203, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kazakhstan and the United States have partnered since 2003 to counter the proliferation of weapons of mass destruction. The US Department of Defense (US DoD) has funded threat reduction programs to eliminate biological weapons, secure material in repositories that could be targeted for theft, and enhance surveillance systems to monitor infectious disease outbreaks that would affect national security. The cooperative biological research (CBR) program of the US DoD's Biological Threat Reduction Program has provided financing, mentorship, infrastructure, and biologic research support to Kazakhstani scientists and research institutes since 2005. The objective of this paper is to provide a historical perspective for the CBR involvement in Kazakhstan, including project chronology, successes and challenges to allow lessons learned to be applied to future CBR endeavors. A project compendium from open source data and interviews with partner country Kazakhstani participants, project collaborators, and stakeholders was developed utilizing studies from 2004 to the present. An earlier project map was used as a basis to determine project linkages and continuations during the evolution of the CBR program. It was determined that consistent and effective networking increases the chances to collaborate especially for competitive funding opportunities. Overall, the CBR program has increased scientific capabilities in Kazakhstan while reducing their risk of biological threats. However, there is still need for increased scientific transparency and an overall strategy to develop a capability-based model to better enhance and sustain future research. Finally, we offer a living perspective that can be applied to further link related studies especially those related to One Health and zoonoses and the assessment of similar capability-building programs.

Indexed as

biosecuritycooperative biological research (CBR) programglobal health securityKazakhstanone healthzoonoses

Identifiers

PMID31717575
PMCPMC6958332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.